跳至主要内容
临床试验/RBR-8wjq29
RBR-8wjq29尚未招募未知

Evaluation of Isoniazid 300 mg Implementation for the Treatment of Latent Tuberculosis Infection in Brazil

niversidade Federal do Espirito Santo0 个研究点开始时间: 2019年12月27日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 50Y(—)

入选标准

  • Patients who agree with the consent form; Patients of both sexes; Indication for treatment with isoniazid 300mg per day; With access to mobile smartphone with Android operating system; patients who know or not read; age between 18 and 50 years;

排除标准

  • Patients on treatment for rifampicin or already on treatment for latent tuberculosis; patients with HIV; pregnant or intending to become pregnant; homeless patients; deprived of liberty; Patients referred for treatment over 6 months.

研究者

发起方
niversidade Federal do Espirito Santo

相似试验